Mercy's Dr. Jennifer Joh Addresses Triple Negative Breast Cancer

January 2, 2018
Mercy Breast Center

 

A breast cancer diagnosis can be complex. There are varying types of the disease.

Breast cancer that is not supported by the hormones estrogen and progesterone nor by the presence of too many HER-2 receptors is called triple negative. It's more rare and does not respond to typical breast cancer medicines.

According to dedicated breast surgeon Dr. Jennifer Joh of The Hoffberger Breast Center at Mercy Medical Center, there is tremendous research happening right now.

"Triple negative breast cancer is a very hot topic because we don't really have great ways of treating the breast cancer, and it does tend to be more aggressive and it does tend to lead to reduced survival rates," Dr. Joh said.

Triple negative accounts for just 10 to 20 percent of breast cancer cases and is more common in young women, African-Americans, Hispanics and those with the BRCA1 gene mutation.

View Dr. Jennifer Joh’s interview regarding triple negative breast cancer.


Dan Collins - Senior Director of Media Relations at Mercy Medical Center

Dan Collins, Senior Director of Media Relations

Email: dcollins@mdmercy.com Office: 410-332-9714 Cell: 410-375-7342

About Mercy

Founded in 1874, Mercy Medical Center is a university-affiliated medical facility named one of the top 100 hospitals in the U.S. by Thomson-Reuters with a national reputation for women’s health. Mercy is home to the nationally acclaimed Weinberg Center for Women’s Health and Medicine as well as the $400+ million, 20-story Mary Catherine Bunting Center. For more information visit Mercy online at www.mdmercy.com, Facebook, Twitter or call 1-800-MD-MERCY.

News and Events